
Journal Menu
► ▼ Journal Menu-
- Pathogens Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
21 March 2025
Meet Us at the 44th Annual Meeting of the American Society for Virology (ASV 2025), 14–17 July 2025, Montréal, Québec, Canada

MDPI journals will be attending the 44th Annual Meeting of the American Society for Virology (ASV 2025) as exhibitors. This meeting will be held in Montréal, Québec, Canada, from 14 to 17 July 2025.
The American Society for Virology’s annual meeting provides a forum with which to promote discussion and collaboration among scientists active in all aspects of virology. Attendees will have the chance to learn about virology, share their research, and network with other scientists.
This conference is hosted by McGill University at the Palais des congrès de Montréal. The annual meeting usually attracts 1500–1800 national and international scientists for a program crafted from over 1000 participant-submitted abstracts, 20 invited symposium speakers, and 6 distinctive state-of-the-art speakers.
The following MDPI journals will be represented at the conference:
- Viruses;
- Vaccines;
- Pathogens;
- CIMB;
- COVID;
- Life;
- J;
- Biomolecules;
- Aerobiology.
If you are planning to attend this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference and our booth, please visit https://asv.org/asv2025/.
18 March 2025
Meet Us at the 9th European Congress of Virology 2025 (ECV2025), 27–30 April 2025, Cavtat, Croatia

MDPI will attend the 9th European Congress of Virology 2025 (ECV2025) as an exhibitor. This meeting will be held in Cavtat, Croatia, from 27 to 30 April 2025.
ECV provides a unique opportunity for European virologists from all fields of virus research to present their work, exchange ideas, and plan new exciting projects. ECV organizing and scientific committees are busy preparing a high-quality and diverse program for attendees.
The following MDPI journals will be represented at the conference:
- Viruses;
- Pathogens;
- Diagnostics;
- COVID;
- Microbiology Research.
If you are planning to attend the above conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference and our booth, please visit the following website: https://eusv-congress.eu/.
18 March 2025
Meet Us at the International Virus Bioinformatics Meeting 2025 (ViBioM2025), 13–15 May 2025, Lisbon, Portugal

MDPI will attend the International Virus Bioinformatics Meeting 2025 (ViBioM2025) as an exhibitor. This meeting will be held in Lisbon, Portugal, from 13 to 15 May 2025.
The International Virus Bioinformatics Meeting (ViBioM) is a pioneering conference uniting leading scientists at the intersection of virology and bioinformatics, fostering collaboration and innovation in the study of viruses.
As we navigate the rapidly changing landscape of viruses and their impact on human health and the broader ecosystem, it has become increasingly essential for virologists and bioinformaticians to work together. ViBioM2025 provides a dynamic platform for the exchange of knowledge, cutting-edge research, and groundbreaking discoveries. It will offer an excellent opportunity to present and discuss your research, (re)connect with colleagues and friends, and establish new collaborations. Its mission is to create an environment where both experts and newcomers can engage in meaningful discussions and build lasting connections.
The scientific program will cover a wide array of topics, ensuring a comprehensive and enriching experience for all attendees.
The following MDPI journals will be represented at the conference:
- Viruses;
- Pathogens;
- CIMB;
- COVID;
- J;
- Microorganisms;
- TropicalMed.
If you are planning to attend this conference, please feel free to start a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference and our booth, please visit https://evbc.uni-jena.de/events/vibiom2025/.
17 March 2025
Pathogens Accepted into MEDLINE

We are pleased to inform you that the journal Pathogens (ISSN: 2076-0817) has been officially accepted into MEDLINE, starting with Volume 13, Issue 1 (2024). This recognition underscores the high-quality research and dedication of our Editorial Board, Guest Editors, reviewers, and authors. Pathogens is now indexed within all the important databases in this field, such as Scopus, SCIE, MEDLINE, PubMed, and PMC. More indexing information can be found at https://www.mdpi.com/journal/pathogens/indexing.
To make the most of this opportunity, we would like to invite you to contribute to Pathogens. If you have a paper on any topic within the journal's scope, please feel free to submit here.
We look forward to working with you in the future.
Pathogens Editorial Office
14 March 2025
Free Media Partnership Between Pathogens and the 24th International Pathogenic Neisseria Conference, 30 March–4 April 2025, Florence, Italy

Conference: The 24th International Pathogenic Neisseria Conference
Date: 30 March–4 April 2025
Place: Florence, Italy
We are organizing the 24th International Pathogenic Neisseria Conference, which will be held in Florence, Italy, from 30 March to 4 April 2025.
The IPNC is a biannual scientific meeting that engages basic and translational scientists with interest in two genetically related bacterial pathogens, Neisseria meningitidis, which induces devasting diseases such as meningitis and sepsis, and Neisseria gonorrhoeae, a WHO priority pathogen resistant to most antibiotics, causing more than 80 million of sexually transmitted diseases.
Both diseases are of great public health importance in all continents and in most countries, and their prevalence has reached a critical point, thus necessitating a change in science, policy, investment and focus in high-, medium- and low-income countries.
In the case of meningococcus, for the first time in history, we have vaccines covering all pathogenic serotypes, available for infant and for adult populations as single vaccines and in combinations. During the conference, discussions will be held on epidemiology, vaccine coverage to estimate country needs, health economic evaluations, recommendations and post-licensure safety and efficacy monitoring. In addition, we will organize a round table on the WHO agenda on defeating meningitis by 2030 and the opportunity provided by the recent licensure of the ACYWX conjugate for low-income countries to eliminate such a devasting disease, especially in the Sub-Saharan African meningitis belt.
In the case of gonococcus, for the first time since the failures of the 1970s, we have proof of principle that an efficacious vaccine for gonococcus is possible. Moreover, a vaccine against meningococcus B has been shown to provide partial protection from gonococcal infection, and this observation is encouraging new investments to bring novel vaccines against a bacterium resistant to most antibiotics to clinical trials as it may become untreatable and can lead to more than 700,000 cases of the disease in the USA and more than 80 million cases globally. Infection can cause pelvic inflammatory disease, infertility, and ectopic pregnancies and increases the transmission of and susceptibility to the human immunodeficiency virus 1 (HIV-1), thus being designated a high-priority pathogen by the WHO.
The IPNC2025 represents a great opportunity to share ideas and data on recent advances in basic, clinical and translational research as well as promote exchanges between academia and industry to stimulate new and relevant areas of research. This conference aims to gather scientists and clinicians from all over the world to connect in person and brainstorm solutions and ideas related to understanding, managing and reducing the burden of disease caused by Neisseria meningitidis and Neisseria gonorrhoeae.
The IPNC covers a wide range of topics including host responses to infection, bacterial responses and adaptation, clinical disease presentation and evaluation, diagnostics, therapy and prevention through new vaccine development, evaluation and implementation, antimicrobial resistance, epidemiology, population genomics, host–pathogen interactions, molecular physiology, gene regulation and modeling.
27 February 2025
More than 300 MDPI Journals Indexed in Web of Science
MDPI is pleased to share a significant milestone in its mission to advance scholarly research and promote the dissemination of knowledge—300+ MDPI journals are now indexed in Web of Science (WoS). This milestone highlights the global recognition, interdisciplinary impact and enhanced visibility of our journals. It also reflects our adherence to rigorous editorial standards, scientific integrity, and our mission to foster open scientific exchange in all forms, across all disciplines.

To explore the full list of our journals indexed in WoS, please visit https://www.mdpi.com/about/journals/wos. Beyond expanding the coverage of our publications in the leading academic databases, we are dedicated to ensuring that our journals are included in as many scope-specific databases as possible. This increases the visibility of our authors’ work and extends the reach of their significant data.
This milestone would not have been possible without the efforts and expertise of our academic editors, reviewers and authors. Their commitment and collaboration have been instrumental in creating an inclusive, accessible, and impactful publishing platform. We also extend our gratitude to the global research community for their trust as we continue to break new ground in academic publishing. This milestone is not just a celebration of MDPI’s progress but also recognition of the collective strides made by researchers worldwide.
As we celebrate this remarkable accomplishment, MDPI remains steadfast in its commitment to open access publishing and ensuring that high-quality research reaches and inspires a global audience.
17 February 2025
MDPI Celebrates Excellence in Medical Research with Early Career Researcher Awards

MDPI, a pioneer in scholarly open access publishing, and the Lee Kong Chian School of Medicine (LKCMedicine), Singapore, proudly announce the successful conclusion of the first edition the MDPI Early Career Researcher Awards. The awards, which recognize outstanding contributions to medical and biomedical research, were presented to six exceptional researchers during an awards ceremony held at LKCMedicine HQ Building on 28 November 2024.
|
|
Honoring Excellence in Research
The awards recognize exceptional postdoctoral researchers and Ph.D. students who have demonstrated outstanding originality, innovation, and impact in their respective fields. We are honored to announce the winners of the 2024 edition:
Early Career Researcher (Postdoc) Award:
- Dr. Theresia Handayani Mina, “Adiposity and Metabolic Health in Asian Populations: An Epidemiological Study Using Dual-Energy X-Ray Absorptiometry in Singapore”;
- Dr. Erfan Rezvani Ghomi, “Wound Healing Improvement by Novel Aligned Antimicrobial Nanofibrous 3D Scaffolds”;
- Dr. Yadollah Ranjbar Slamloo, “Functional Alterations of The Prefrontal Circuit Underlying Cognitive Aging in Mice”.
Early Career Researcher (Ph.D.) Award:
- Pritisha Rozario, “Mechanistic Basis for Potassium Efflux-Driven Activation of the Human NLRP1 Inflammasome”;
- Michelle Law Cheok Yien, “Chikungunya Virus Nonstructural Protein 1 is a Versatile RNA Capping and Decapping Enzyme”;
- Yin Ruoyu, “The Use of Digital Mental Health and Wellbeing Tools in Older Adults: A Mixed Method Study”.
Our collaboration highlights a shared commitment to recognizing exceptional talent and research within the academic community, addressing today’s healthcare challenges, and inspiring continued innovation.
|
|
|
|
|
|
Looking Ahead to 2025
Building on the success of the first edition, MDPI and LKCMedicine are excited to announce that the 2025 MDPI Early Researcher Awards will continue to celebrate excellence and innovation in medical research. The next edition promises to expand its scope, introducing new categories and providing even greater recognition for impactful research.
Further details on the 2025 awards, including nomination criteria and timelines, will be shared in the coming months. We remain committed to fostering a culture of research excellence and collaboration within the global scientific community.
|
14 February 2025
Meet Us at the Joint Parasitology Spring Meeting 2025, 11–14 March 2025, Würzburg, Germany

Conference: Joint Parasitology Spring Meeting 2025
Date: 11–14 March 2025
Location: Würzburg, Germany
MDPI will be attending the Joint Parasitology Spring Meeting 2025 as an exhibitor, which will be held from 11 to 14 March 2025 in Würzburg, Germany. The meeting is organized by the British Society for Parasitology (BSP), the German Society for Parasitology (DGP), and the Swiss Society for Tropical Medicine and Parasitology (SSTMP).
This exciting meeting will unite leading experts, researchers, and professionals in parasitology to share their knowledge, present their latest discoveries, and provide valuable networking opportunities.
The following MDPI journals will be represented at the meeting:
- Pathogens;
- Parasitologia;
- Microorganisms;
- Veterinary Sciences;
- TropicalMed;
- Microbiology Research;
- Ecologies;
- Zoonotic Diseases.
If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following website: https://parasitology-meeting.de/.
5 February 2025
MDPI INSIGHTS: The CEO's Letter #20 - Beijing, Singapore, Bangkok, JAMS, Jisc

Welcome to the MDPI Insights: The CEO's Letter.
In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.
Opening Thoughts
2024 Annual Meeting – Beijing (15 January 2025)
You haven’t truly experienced a New Year’s celebration until you’ve attended one of MDPI’s Chinese Annual Meeting festivities. This year I visited our annual meeting in Beijing, held on the 15th of January.
Imagine this: stepping into a banquet hall filled with 140 tables and about 1,400 colleagues from our Beijing offices, all gathered to share in a six-hour event. The agenda included year-end speeches and presentations, a variety of performances by our colleagues, a selection of awards honouring local employees for their work, group photos for the memories, and a dinner.
This may have been one of the largest events I have attended. For those unaccustomed to such an event, it might seem overwhelming, but it was quite the opposite. The atmosphere was one of celebration as everyone came together to support their peers and celebrate the achievements of 2024.
I was honoured to deliver the opening speech and a presentation highlighting our growth and investment in MDPI’s most valuable asset: our people.
“Our editorial teams represent MDPI at its finest”
I want to give special recognition to the editorial department, across all of our offices, which forms the heart of our business. These teams are the frontline communicators with our authors, reviewers, and guest editors, creating a smooth experience of processing our manuscripts. Their professionalism and kindness are often highlighted as key drivers of satisfaction with MDPI. For this, I extend my deepest gratitude to all our editorial staff, across every office. They truly represent MDPI at its finest.
Beijing is home to two of our offices, with just over 800 employees in Tongzhou and over 600 in Haidian. Thank you to our administrative teams and everyone involved in organizing these New Year’s celebrations across all offices. These events provide a moment to reflect on our shared accomplishments and appreciate the positive impact each of you has on our culture.
MDPI Offices in China
While the history of MDPI begins in Basel, Switzerland, the story of MDPI is very much rooted in China. Below is a list of MDPI’s current offices in China and their respective dates of inauguration:
- 2008: Beijing (Tongzhou, Haidian)
- 2013: Wuhan (Hankou, Guanggu)
- 2019: Tianjin
- 2021: Dalian
- 2021: Nanjing
To date, over 381,000 MDPI research articles have been published by authors affiliated with Chinese institutions, making China our largest market. This is reflected not only in the volume of publications but also in the scale of our workforce supporting local operations and contributing to global success.
While no new offices in China were launched between 2022 and 2024 due to the pandemic and strategic planning, we remain committed to future growth here. Our plans include expanding operations as we continue to build our global workforce.
We look forward to a year filled with continued collaboration, growth, and shared success.
“We remain committed to future growth in China”
Impactful Research
MDPI and Jisc Consortium Extend Open Access Agreement for 2025
I’m pleased to share that MDPI has extended its agreement with the Jisc consortium in the UK for 2025. This renewal strengthens our partnership with UK institutions and reaffirms our shared commitment to advancing open access publishing.
Jisc is the UK’s not-for-profit digital, data, and technology agency supporting tertiary education, research, and innovation. Through initiatives such as our agreement, Jisc helps institutions access essential digital resources and infrastructure to support researchers. Currently, 62 UK institutions are part of our Institutional Open Access Program (IOAP) through this partnership.
Authors from participating institutions benefit from discounts on article processing charges (APCs), with even greater support for institutions that centrally fund APCs. This helps researchers focus on their work while simplifying the publishing process.
A full list of participating institutions can be found here.
As Becky Castellon, our Institutional Partnerships Manager, puts it: “Extending our agreement with Jisc is a reward for the strong partnership we’ve built with research institutions throughout the UK.”
At MDPI, we are dedicated to making research more accessible while reducing administrative burdens for institutions and authors. Open access publishing is at the heart of what we do, and we’re proud to expand its reach in the UK and beyond.
Inside MDPI
Visit to MDPI's Singapore office
During my January trip to some of our APAC offices, I also had the pleasure of visiting our Singapore office for the first time. It’s exciting to see how much the team has grown, now numbering over 55 staff members, with more joining us in February.
Welcoming and Supporting New Team Members
“Experienced staff play an important role in mentoring new hires”
I had the opportunity to connect with both experienced colleagues and new team members who are currently embarking on their careers. This visit reminded me of what it was like when I was in their shoes. I encourage all of us to engage new colleagues with empathy, as we have all been in their position. By creating a welcoming and supportive environment, we can help them settle in and learn about the corporate world, MDPI and our mission.
Experienced staff play an important role in mentoring and guiding new hires, most of whom are transitioning from academia to their first job. I’m especially grateful to colleagues such as Colin Chen, Alicia Ren, Yu Nwe Soe, Colin Wee, Amy Cham and other senior members who have contributed to shaping the culture and work environment in Singapore.
Building MDPI’s Positive Reputation
During my visit, I spoke with the office staff about the importance of their roles in building a positive reputation that helps create trust in MDPI. I shared how every interaction and communication point contributes to the marketing of MDPI and our journals. I also highlighted the career development opportunities available as MDPI continues to grow.
Connecting with the Singapore Marketing Team
I also spent time connecting directly with the Singapore Marketing team, which has quickly grown to 15 young and ambitious members. They are eager to learn and are actively contributing to our journal and corporate marketing activities. I shared insights into our corporate marketing structure and strategy and look forward to supporting them as they grow.
During the visit, I was joined by my colleague Dr. Constanze Schelhorn, Head of Indexing, who provided training on indexing. This training was greatly appreciated by the local staff.
Meeting with Prof. Dr. Manoj Gupta
Lastly, we had the privilege of meeting Prof. Dr. Manoj Gupta, Editor-in-Chief (EiC) of Technologies since 2016 and Section EiC of Metals.
Prof. Gupta is an active decision-maker for the journal and a great brand ambassador for MDPI.
Prof. Gupta has helped sustainably scale Technologies, which now has a 4.2 Impact Factor and a 6.7 CiteScore, ranking Q1 in the JCR category of Engineering and Q1 in the CiteScore category of Computer Science.
During our meeting, we discussed strategies for Institutional Open Access Partnership agreements and ways to promote MDPI journals in Singapore.
PS. During the visit, we also had the chance to participate in Lo Hei, also known as Yee Sang or the “prosperity toss.” This is a raw fish salad traditionally enjoyed during Chinese New Year and is particularly popular among Chinese communities in Singapore, Malaysia, and Indonesia. Everyone gathers around the table as the ingredients are added one by one, and then the salad is mixed together. It was a fun experience to take part in this New Year tradition!
Coming Together for Science
JAMS – Journal & Article Management System
I am excited to announce the official relaunch of JAMS (Journal & Article Management System), one of MDPI’s key initiatives to support academic publishers worldwide.
With this relaunch, JAMS now offers new pricing models and flexible solutions for small-scale journals, commercial publishers, and university presses. We have also redesigned the JAMS website to enhance the user experience.
“JAMS is a testament to our commitment to simplifying the publishing process”
Explore the new website here: jams.pub
It’s also great to see the JAMS team expanding our presence at conferences and on social media to engage more effectively with the academic community.
Recently, Facundo Santomé (Senior Marketing Manager) and Alex Ramos (Senior Marketing Specialist) represented JAMS at the APE 2025 conference in Berlin, highlighting how our platform empowers small and independent publishers to streamline and scale their journal management.
JAMS was built to change that by adapting to the unique requirements of each publisher.
At MDPI, we continually invest in our growth – not only by expanding our operations and staff but also by developing innovative products that serve the academic and publishing community at large. JAMS, with its comprehensive suite of journal management tools, is a testament to our commitment to simplifying the publishing process for our partners.
Imagine a submission system that frees up your time for strategy, innovation, and impactful publishing.
Under the leadership of Silvano Bonfatti (Product Manager, MDPI), the JAMS team has conducted in-depth market research to understand the challenges publishers face: endless administrative tasks, inefficient workflows, and systems that don’t always meet their needs.
If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.
What Sets JAMS Apart?
- Scalability – Whether you're a niche journal or managing thousands of submissions, JAMS grows with you.
- End-to-End Workflow – From submission to peer review and final publication, everything is in one place.
- Automation That Works for You – Say goodbye to chasing reviewers and formatting issues, so that you can focus on quality instead.
- Built by Publishers, for Publishers – JAMS is backed by MDPI’s expertise; we know exactly what it takes to run a journal smoothly.
- Flexible & Fair Pricing – Supporting journals of all sizes, with special rates for non-profits and publishers in the Global South.
Partners Who Already Trust JAMS
If you believe JAMS could benefit any of your network contacts, please share our website. Contact the JAMS team. They are always ready to assist with your publishing needs.
Closing Thoughts
Visit to MDPI's Bangkok office
To conclude my APAC trip, I had the pleasure of visiting our Bangkok office from 22 to 24 January. The office has grown significantly, closing 2024 with a total of 445 colleagues across various departments, including Editorial, Production, Conference, Training, Journal Relationship Specialists (JRS), Managing Editors, and supporting teams in HR, Admin, IT, and Finance.
I would like to praise our Bangkok management team for their excellent work in supporting our growth and creating a positive work environment. Our colleagues here are humble, talented, hardworking, and appreciative of MDPI’s mission.
Thailand was among MDPI’s top 30 markets in 2024 for total publications. With our office in Bangkok, we have an opportunity to further promote open access while supporting local researchers and institutions. This includes open access discounts, author training sessions, conference sponsorships, and other initiatives. We currently have 25 Editorial Board Members (EBMs) from Thailand and will work on expanding this network.
Engaging with Group Leads
“Group leads play an important role in creating a safe, positive environment”
During my visit, I met with our group leads to highlight their crucial role in managing journal performance and mentoring new employees, especially given our increased hiring targets. Many new hires are early in their careers and require training, development, and support. Group leads play an important role in creating a safe, positive environment that fosters professional growth while maintaining MDPI’s reputation for service quality.
To wrap up the session, I added a personal touch by holding the door and giving everyone high-fives – a small gesture to show appreciation, boost morale, and strengthen team spirit. It’s important for our colleagues to feel seen, heard, and valued.
University Visit: King Mongkut’s University of Technology North Bangkok (KMUTNB)
We also visited King Mongkut’s University of Technology North Bangkok (KMUTNB) to explore collaboration opportunities.
Our discussions focused on: Institutional Open Access Partnership (IOAP), Author training sessions, Conference sponsorships, Student employment initiatives, and more.
This visit reinforced the importance of building strong relationships with local universities, ensuring we continue to support and engage with the academic community in Thailand.
“My time in Bangkok was productive and inspiring”
My time in Bangkok was productive and inspiring. The senior team has done a great job in growing the office and creating a supportive, high-performing environment. I look forward to seeing continued success from our colleagues in Thailand.
Chief Executive Officer
MDPI AG
26 January 2025
World Neglected Tropical Diseases Day—30 January 2025

On 31 May 2021, the World Health Assembly (WHA) recognized 30 January as World Neglected Tropical Disease (NTD) Day. This decision formalized 30 January as a day to create better awareness on the devastating impact of NTDs on the poorest populations around the world. The day is also an opportunity to call on everyone to support the growing momentum for the control, elimination and eradication of these diseases.
We would like to recommend some related articles, Special Issues, and journals in the field of medicine & pharmacology as suitable communication platforms for you. We believe that sharing research like this can help raise awareness of NTDs.
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
“A Fatal Case of Presumptive Diagnosis of Leptospirosis Involving the Central Nervous System”
by Christina Alexopoulou, Athanasia Proklou, Sofia Kokkini, Maria Raissaki, Ioannis Konstantinou and Eumorfia Kondili
Healthcare 2024, 12(5), 568; https://doi.org/10.3390/healthcare12050568
“Evaluation of an Artificial Intelligence-Based Tool and a Universal Low-Cost Robotized Microscope for the Automated Diagnosis of Malaria”
by Carles Rubio Maturana, Allisson Dantas de Oliveira, Francesc Zarzuela, Alejandro Mediavilla, Patricia Martínez-Vallejo, Aroa Silgado, Lidia Goterris, Marc Muixí, Alberto Abelló, Anna Veiga et al.
Int. J. Environ. Res. Public Health 2025, 22(1), 47; https://doi.org/10.3390/ijerph22010047
“Chagas Disease in the Non-Endemic Area of Rome, Italy: Ten Years of Experience and a Brief Overview”
by Maria Letizia Giancola, Andrea Angheben, Laura Scorzolini, Stefania Carrara, Ada Petrone, Antonella Vulcano, Raffaella Lionetti, Angela Corpolongo, Rosalia Marrone, Francesca Faraglia et al.
Infect. Dis. Rep. 2024, 16(4), 650-663; https://doi.org/10.3390/idr16040050
“Uptake and Effectiveness of Intermittent Preventive Treatment with Sulfadoxine-Pyrimethamine during Pregnancy in Africa: A Scoping Review”
by Gifty Osei Berchie, Patience Fakornam Doe, Theodora Dedo Azu, Joyce Agyeiwaa, Gifty Owusu, Christian Makafui Boso, Naomi Kyeremaa Yeboa, Dorcas Frempomaa Agyare, Irene Korkoi Aboh, Bernard Nabe et al.
Diseases 2024, 12(9), 203; https://doi.org/10.3390/diseases12090203
“Laparoscopic Management of Multiple Liver, Omental, Mesenteric, Peritoneal, and Round Ligament Hydatid Cysts—A Rare Report of a Case and a Systematic Literature Review”
by Alin Mihetiu, Dan Georgian Bratu, Ciprian Tanasescu, Bogdan Ioan Vintilă, Alexandra Sandu, Mariana Sandu, Dragos Serban, Dan Sabau and Adrian Hasegan
J. Pers. Med. 2024, 14(2), 205; https://doi.org/10.3390/jpm14020205
“False-Positive Malaria Rapid Diagnostic Test Likely Due to African Tick Bite Fever: A Case Report”
by Rahel T. Zewude, Syed Zain Ahmad, Tom Joseph and Andrea K. Boggild
Reports 2024, 7(4), 100; https://doi.org/10.3390/reports7040100
“Increasing Risk of Tick-Borne Disease through Growth Stages in Ticks”
by Makoto Kondo, Yoshiaki Matsushima, Takehisa Nakanishi, Shohei Iida, Habe Koji and Keiichi Yamanaka
Clin. Pract. 2023, 13(1), 246-250; https://doi.org/10.3390/clinpract13010022
“Oral Chagas Disease in Colombia—Confirmed and Suspected Routes of Transmission”
by Norman L. Beatty, Catalina Arango-Ferreira, Lídia Gual-Gonzalez, Sara Zuluaga, Melissa S. Nolan and Omar Cantillo-Barraza
Trop. Med. Infect. Dis. 2024, 9(1), 14; https://doi.org/10.3390/tropicalmed9010014
“Global Patterns of Trends in Incidence and Mortality of Dengue, 1990–2019: An Analysis Based on the Global Burden of Disease Study”
by Irena Ilic and Milena Ilic
Medicina 2024, 60(3), 425; https://doi.org/10.3390/medicina60030425
“DengueFog: A Fog Computing-Enabled Weighted Random Forest-Based Smart Health Monitoring System for Automatic Dengue Prediction”
by Ashima Kukkar, Yugal Kumar, Jasminder Kaur Sandhu, Manjit Kaur, Tarandeep Singh Walia and Mohammed Amoon
Diagnostics 2024, 14(6), 624; https://doi.org/10.3390/diagnostics14060624
“Global Fight against Malaria: Goals and Achievements 1900–2022”
by Marc Thellier, Ayawovi Arlene Jessicka Gemegah and Ilhame Tantaoui
J. Clin. Med. 2024, 13(19), 5680; https://doi.org/10.3390/jcm13195680
“Oropouche Virus Exposure in Febrile Patients during Chikungunya Virus Introduction in the State of Amapá, Amazon Region, Brazil”
by Raquel Curtinhas de Lima, Helver Gonçalves Dias, Thiara Manuele Alves de Souza, Débora Familiar-Macedo, Edcelha D’Athaide Ribeiro, Valmir Corrêa e Corrêa, Alex Pauvolid-Corrêa, Elzinandes Leal de Azeredo and Flávia Barreto dos Santos
Pathogens 2024, 13(6), 469; https://doi.org/10.3390/pathogens13060469
“Adenovirus-Mediated Expression of Dengue Virus 2 Envelope Ferritin Nanoparticles Induced Virus-Specific Immune Responses in BALB/c Mice”
by M.S.B.W.T.M. Nipuna Sudaraka Tennakoon, Ji-Hoon Ryu, Yong-Sam Jung, Yingjuan Qian and Hyun-Jin Shin
Microbiol. Res. 2024, 15(3), 1913-1923; https://doi.org/10.3390/microbiolres15030128
“Evolution of the Quinoline Scaffold for the Treatment of Leishmaniasis: A Structural Perspective”
by Carlos F. M.Silva, Diana C. G. A. Pinto, Pedro A. Fernandes and Artur M. S. Silva
Pharmaceuticals 2024, 17(3), 285; https://doi.org/10.3390/ph17030285
“Prevalence of Intestinal Parasites, Protozoans and Soil-Transmitted Helminths, in Children from Communities of Northern Argentina after the Interruption of Deworming”
by Ernesto Candela, Rubén O. Cimino, Leonardo Sandon, Carla Muñoz-Antoli and María Victoria Periago
Parasitologia 2024, 4(2), 172-183; https://doi.org/10.3390/parasitologia4020015
“Global Lipidomics Reveals the Lipid Composition Heterogeneity of Extracellular Vesicles from Drug-Resistant Leishmania”
by Sehyeon (Erica) Kim, Ana Victoria Ibarra-Meneses, Christopher Fernandez-Prada and Tao Huan
Metabolites 2024, 14(12), 658; https://doi.org/10.3390/metabo14120658
Special Issue: “Infectious Disease Prevention and Public Health Promotion: Second Edition” |
Special Issue: “Advances in Molecular Diagnosis in Neglected Tropical Diseases” |
|
|
Special Issue: “One Health and Neglected Zoonotic Diseases” |
Special Issue: “Dysbiosis and Metabolic Disorders of the Microbiota” |
|
|